1. Home
  2. TPCS vs VERU Comparison

TPCS vs VERU Comparison

Compare TPCS & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechPrecision Corporation Common stock

TPCS

TechPrecision Corporation Common stock

N/A

Current Price

$4.49

Market Cap

44.9M

Sector

Industrials

ML Signal

N/A

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.41

Market Cap

39.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPCS
VERU
Founded
1956
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.9M
39.8M
IPO Year
N/A
1990

Fundamental Metrics

Financial Performance
Metric
TPCS
VERU
Price
$4.49
$2.41
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$25.00
AVG Volume (30 Days)
53.3K
130.1K
Earning Date
11-13-2025
12-16-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$33,564,000.00
$16,886,419.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.15
337.24
52 Week Low
$2.05
$2.11
52 Week High
$6.25
$14.20

Technical Indicators

Market Signals
Indicator
TPCS
VERU
Relative Strength Index (RSI) 46.43 38.72
Support Level $4.41 $2.11
Resistance Level $4.70 $2.51
Average True Range (ATR) 0.30 0.19
MACD 0.03 0.04
Stochastic Oscillator 39.33 42.67

Price Performance

Historical Comparison
TPCS
VERU

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Share on Social Networks: